http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014200037-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbd4bb68100d081729a8f48251547134 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 2014-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57571fdd8401d87e8095e2dac2c69577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b394ad89fc900c8c2c66a2e6ab02fd2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02216743806e7a6a7fbaad265a462ea3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af74f98b90643e08baf00fc4c8fff109 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_104df86ef8a69618d58b248ff859bedd |
publicationDate | 2016-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2014200037-B2 |
titleOfInvention | Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations |
abstract | The disclosure describes alterations in ERG gene expression. ERG isoforms and promoter sequence of the ERG gene that are involved in, or associated with, prostate cancer are provided. The disclosure further provides therapeutic compositions and methods of detecting, diagnosing, prognosing, and treating prostate cancer, including biomarkers for detecting the expression of two or more of the following genes PSA/KLK3, PMEPAI, NKX3. 1, ODC1, AMDI, and ERG. 4997610_1 (GHMatters) P80589.AU.1 |
priorityDate | 2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1299.